Healthcap

Stockholm · healthcap.eu

  • Pharma/Biotech

HealthCap is a Stockholm-based life science venture firm investing in targeted therapies for rare diseases, cancers and genetic diseases.

Raising a round? See which funds fit your startup. Your #1 match is free. No signup, no card.

Updated · Sources: fund website

Would Healthcap back you?

Stage
Series A–Pre Exit

Overview

Healthcap at a glance

Healthcap is a Series A to Pre Exit venture capital firm based in Stockholm that invests in Pharma/Biotech, Therapeutics and Cell Therapy. Partners at Healthcap include Alex Valcu (Partner) and Anki Forsberg (Partner and Chairman).

Stage
Series A, Series B, Series C, Clinical, Pre Exit
Sectors
Pharma/Biotech, Therapeutics, Cell Therapy, Oncology
Headquarters
Stockholm
Cold inbound
Warm intro preferred

Investment thesis

HealthCap invests in innovative life science companies developing targeted therapies for rare diseases, cancers, and genetic diseases with high unmet medical need to impact healthcare and society.

Stated on healthcap.euWEBSITE

What sets Healthcap apart

  • Medical expertise embedded in team (medicine, finance, biochemistry backgrounds)
  • 28+ year track record with 34 approved drugs and 48 IPOs
  • Focus on portfolio company creation not just investment
  • Active role in European life sciences ecosystem and coalitions

What the portfolio shows

DryPowder's read of the portfolio is on paid plansSee Starter

Portfolio 3

Backed: Vicore Pharma, Aprea Therapeutics, Adcendo ApS

All 3 portfolio companies are on paid plansSee Starter

Partners

19 partners at Healthcap

Partner emails are on paid plans.See plans

Similar funds

Funds like Healthcap

Investor lists that include Healthcap

FAQ

Questions about Healthcap

What does Healthcap invest in?

Healthcap is a Series A, Series B, Series C, Clinical, Pre Exit stage Pharma/Biotech, Therapeutics, Cell Therapy, Oncology investor, primarily investing in Europe. Their thesis: HealthCap invests in innovative life science companies developing targeted therapies for rare diseases, cancers, and genetic diseases with high unmet medical need to impact healthcare and society.

What makes Healthcap different from other funds?

Healthcap stands out on 4 points: Medical expertise embedded in team (medicine, finance, biochemistry backgrounds); 28+ year track record with 34 approved drugs and 48 IPOs; Focus on portfolio company creation not just investment; Active role in European life sciences ecosystem and coalitions.

How do I reach Healthcap?

Healthcap does not generally take cold inbound; a warm introduction from a founder or investor the firm knows is the usual path.

Sources

Updated